24
Participants
Start Date
October 31, 2014
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
midazolam
single dose of midazolam given as oral solution (day 1 of visits 2 and 3)
caffeine
single dose of caffeine given as tablets (day 1 of visits 2 and 3)
digoxin
single dose of digoxin given as tablets (day 3 of visits 2 and 3)
warfarin
single dose of warfarin given as tablets (day 1 of visits 2 and 3)
omeprazole
single dose of omeprazole given as tablet (day 1 of visits 2 and 3)
BI 187004
multiple doses of BI 187004 given as tablets (day 7-12 of visit 2 and day 1-6 of visit 3)
metoprolol
single dose of metoprolol given as tablets (day 1 of visits 2 and 3)
1307.19.1 Boehringer Ingelheim Investigational Site, Biberach
Lead Sponsor
Boehringer Ingelheim
INDUSTRY